Luxembourg venture capital firm backing early-stage healthcare technology companies across extended Europe, particularly DACH and Benelux. Its Catalpa Health Fund I targets pre-seed through Series A businesses addressing healthcare workforce shortages, demographic change and operating costs, including clinical AI and digital diagnostics.
Founded
—
Type
Venture capital
Funds1
Catalpa Health Fund I—
Luxembourg-based early-stage HealthTech fund investing across extended Europe, mainly at pre-seed and seed, with follow-on capacity. Its first closing was announced on 9 December 2025. Founding partner Christian Goergen reports over EUR10 million closed, while EUR30 million is the fund target for 2027. The fund supports prevention and disease management, tools that free healthcare staff time, and software improving clinical workflows; published EUR300,000–1.5 million tickets are not fund size.